Total synthesis and structure revision of the (-)-maduropeptin chromophore

Journal of the American Chemical Society

Volumn 131, Issue 34, 2009, Pages 12072-12073

  Komano, Kazuo ^a   Shimamura, Satoshi ^a   Norizuki, Yutaro ^a   Zhao, Donglin ^a   Kabuto, Chizuko ^a   Sato, Itaru ^a   Hirama, Masahiro ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE COMPONENTS; ANTITUMOR ANTIBIOTICS; CHEMICAL EQUATIONS; DIASTEREOMERIC; NATURAL PRODUCTS; SUGAR MOIETY; TOTAL SYNTHESIS;

ANTIBIOTICS; SUGAR (SUCROSE); SUGARS; SYNTHESIS (CHEMICAL);

CHROMOPHORES;

AGLYCONE; ANTINEOPLASTIC ANTIBIOTIC; DEXTRO SERINE; LACTONE; MADUROPEPTIN; TRICHLOROACETIMIDIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; GLYCOSYLATION; HYDROGEN BOND; ISOMERISM; PROTON NUCLEAR MAGNETIC RESONANCE;

ENEDIYNES;

EID: 69349104800     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja905397p     Document Type: Article

References (36)

1. (a) Zein, N.; Solomon, W.; Colson, K. L.; Schroeder, D. R. Biochemistry 1995, 34, 11591.
2. (b) Schroeder, D. R.; Colson, K. L.; Klohr, S. E.; Zein, N.; Langley, D. R.; Lee, M. S.; Matson, J. A.; Doyle, T. W. J. Am. Chem. Soc. 1994, 116, 9351.
3. (c) Hanada, M.; Ohkuma, H.; Yonemoto, T.; Tomita, K.; Ohbayashi, M.; Kamei, H.; Miyaki, T.; Konishi, M.; Kawaguchi, H.; Forenza, S. J. Antibiot. 1991, 44, 403.
4. (a) Xi, Z.; Goldberg, I. H. Comprehensive Natural Products Chemistry, Eds.; Barton, D. H. R.; Nakanishi, K.; Meth-Cohn, O.; Pergamon: Oxford, 1999; Vol.7, p 553.
5. (b) Smith, A. L.; Nicolaou, K. C. J. Med. Chem. 1996, 39, 2103.
6. For the structure and reactivities of nine-membered enediynes, see: (a) Hirama, M.; Akiyama, K.; Das, P.; Mita, T.; Lear, M. J.; Iida, K.; Sato, I.; Yoshimura, F.; Usuki, T.; Tero-Kubota, S. Heterocycles 2006, 69, 83, and references therein.
7. (b) Usuki, T.; Mita, T.; Lear, M. J.; Das, P.; Yoshimura, F.; Inoue, M.; Hirama, M.; Akiyama, K.; Tero-Kubota, S. Angew. Chem., Int. Ed. 2004, 43, 5249.
8. (c) Hirama, M. Pure Appl. Chem. 1997, 69, 525.
9. (d) Iida, K.; Hirama, M. J. Am. Chem. Soc. 1995, 117, 8875.
10. For synthetic studies of maduropeptin chromophore from our laboratories, see: (a) Norizuki, Y.; Komano, K.; Sato, I.; Hirama, M. Chem. Commun. 2008, 5372.
11. (b) Iso, K.; Inoue, M.; Kato, N.; Hirama, M. Chem. Asian J. 2008, 3, 447.
12. (c) Komano, K.; Shimamura, S.; Inoue, M.; Hirama, M. J. Am. Chem. Soc. 2007, 129, 14184.
13. (d) Kato, N.; Shimamura, S.; Kikai, Y.; Hirama, M. Synlett 2004, 2107.
14. (e) Kato, N.; Shimamura, S.; Khan, S.; Takeda, F.; Kikai, Y.; Hirama, M. Tetrahedron 2004, 60, 3161.
15. (f) Khan, S.; Kato, N.; Hirama, M. Synlett 2000, 1494.
16. For synthetic studies of maduropeptin chromophore from other laboratories, see: (a) Dai, W.-M.; Fong, K. C.; Lau, C. W.; Zhou, L.; Hamaguchi, W.; Nishimoto, S. J. Org. Chem. 1999, 64, 682.
17. (b) Roger, C.; Grierson, D. Tetrahedron Lett. 1998, 39, 27.
18. (c) Suffert, J.; Toussaint, D. Tetrahedron Lett. 1997, 38, 5507.
19. (d) Nicolaou, K. C.; Koide, K.; Xu, J.; Izraelewicz, M. H. Tetrahedron Lett. 1997, 38, 3671.
20. (e) Nicolaou, K. C.; Koide, K. Tetrahedron Lett. 1997, 38, 3667.
21. (f) Magnus, P.; Carter, R.; Davies, M.; Elliott, J.; Pitterna, T. Tetrahedron 1996, 52, 6283.
22. For the structures of related chromoprotein antibiotics, C-1027, see: (a) Iida, K.; Fukuda, S.; Tanaka, T.; Hirama, M.; Imajo, S.; Ishiguro, M.; Yoshida, K.; Otani, T. Tetrahedron Lett. 1996, 37, 4997.
23. (b) Iida, K.; Ishii, T.; Hirama, M.; Otani, T.; Minami, Y.; Yoshida, K. Tetrahedron Lett. 1993, 34, 4079.
24. (c) Yoshida, K.; Minami, Y.; Azuma, R.; Saeki, M.; Otani, T. Tetrahedron Lett. 1993, 34, 2637.
25. Kedarcidin: (d) Ogawa, K.; Koyama, Y.; Ohashi, I.; Sato, I.; Hirama, M. Angew. Chem., Int. Ed. 2009, 48, 1110.
26. (e) Ren, F.; Hogan, P. C.; Anderson, A. J.; Myers, A. G. J. Am. Chem. Soc. 2007, 129, 5381.
27. (f) Kawata, S.; Ashizawa, S.; Hirama, M. J. Am. Chem. Soc. 1997, 119, 12012.
28. (g) Leet, J. E.; Schroeder, D. R.; Hofstead, S. J.; Golik, J.; Colson, K. L.; Huang, S.; Klohr, S. E.; Doyle, T. W.; Matson, J. A. J. Am. Chem. Soc. 1992, 114, 7946.
29. The structure and absolute configuration of 5 was determined by X-ray crystallographic analysis (see Supporting Information).
30. (a) Oki, M. Top. Stereochem. 1983, 14, 1.
31. (b) Oki, M. The Chemistry of Rotational Isomers; Hafner, K.; Lehn, J.-M.; Rees, C. W.; Schleyer, P. von R.; Trost, B. M.; Zahradník, R., Eds.; Springer-Verlag: Berlin, 1993.
32. (c) Myers, A. G.; Hurd, A. R.; Hogan, P. C. J. Am. Chem. Soc. 2002, 124, 4583.
33. (a) Schmidt, R. R. Pure Appl. Chem. 1989, 61, 1257.
34. (b) Schmidt, R. R. Angew. Chem., Int. Ed. Engl. 1986, 25, 212.
35. 1b
36. For a discussion from a view of the hypothetical biosynthetic pathway, see: Van Lanen, S. G.; Oh, T.-j.; Liu, W.; Wendt-Pienkowski, E.; Shen, B. J. Am. Chem. Soc. 2007, 129, 13082.